Literature DB >> 27702933

Erdheim-Chester disease: 25-year history with early CNS involvement.

C M Rice1, C A Hall2, P McCoubrie2, S A Renowden2, N Cohen2, N J Scolding3.   

Abstract

We report a case of Erdheim-Chester disease (ECD) with a 25-year history following initial presentation with diabetes insipidus and brainstem involvement. The exceptionally long history is particularly notable, given that ECD is a life-threatening disorder and there is a recognised association between central nervous system involvement and poor outcome. The case is a timely reminder of the presenting features of the condition, given the emergence of potential new treatment options. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Year:  2016        PMID： 27702933      PMCID： PMC5073707          DOI： 10.1136/bcr-2016-216747

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  9 in total

Review 1.  Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.

Authors:  Carl E Allen; D Williams Parsons
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

2.  Erdheim Chester - a rare disease with unique endoscopic features.

Authors:  Gil Ben-Yaakov; Daniela Munteanu; Ignacio Sztarkier; Alexander Fich; Doron Schwartz
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

3.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

4.  Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies.

Authors:  Fréderic Franconieri; Nicolas Martin-Silva; Hubert de Boysson; Françoise Galateau-Salle; Jean-François Emile; Boris Bienvenu; Achille Aouba
Journal:  Acta Oncol       Date:  2016-03-31       Impact factor: 4.089

5.  CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients.

Authors:  Laurent Arnaud; Baptiste Hervier; Antoine Néel; Mohamed A Hamidou; Jean-Emmanuel Kahn; Bertrand Wechsler; Gemma Pérez-Pastor; Bjørn Blomberg; Jean-Gabriel Fuzibet; François Dubourguet; António Marinho; Catherine Magnette; Violaine Noel; Michel Pavic; Jochen Casper; Anne-Bérangère Beucher; Nathalie Costedoat-Chalumeau; Laurent Aaron; Juan Salvatierra; Carlos Graux; Patrice Cacoub; Véronique Delcey; Claudia Dechant; Pascal Bindi; Christiane Herbaut; Giorgio Graziani; Zahir Amoura; Julien Haroche
Journal:  Blood       Date:  2011-01-14       Impact factor: 22.113

6.  BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease.

Authors:  Maria Giulia Cangi; Riccardo Biavasco; Giulio Cavalli; Greta Grassini; Elena Dal-Cin; Corrado Campochiaro; Barbara Guglielmi; Alvise Berti; Vito Lampasona; Andreas von Deimling; Maria Grazia Sabbadini; Marina Ferrarini; Claudio Doglioni; Lorenzo Dagna
Journal:  Ann Rheum Dis       Date:  2014-03-26       Impact factor: 19.103

7.  Gastrointestinal Erdheim-Chester disease.

Authors:  R Tevlin; A M Cahalane; J O Larkin; A Treacy; D Connaghan; D C Winter
Journal:  Ir Med J       Date:  2014-05

Review 8.  Erdheim-Chester disease.

Authors:  Corrado Campochiaro; Alessandro Tomelleri; Giulio Cavalli; Alvise Berti; Lorenzo Dagna
Journal:  Eur J Intern Med       Date:  2015-04-10       Impact factor: 4.487

9.  Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim-Chester Disease.

Authors:  C Courtillot; S Laugier Robiolle; F Cohen Aubart; M Leban; R Renard-Penna; A Drier; F Charlotte; Z Amoura; P Touraine; J Haroche
Journal:  J Clin Endocrinol Metab       Date:  2015-11-13       Impact factor: 5.958
  9 in total
  1 in total

1.  Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease.

Authors:  Jaume Monmany; Esther Granell; Laura López; Pere Domingo
Journal:  BMJ Case Rep       Date:  2018-10-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.